A Reappraisal of the Antiviral Properties and Immune Regulation Through Dietary Phytochemicals

The document discusses the potential of dietary phytochemicals, derived from plants, in enhancing antiviral therapies, particularly in the context of the COVID-19 pandemic and other aggressive viral infections like ebola, AIDS, influenza, and SARS. It highlights the limitations of current antiviral treatments due to issues like mutations and drug resistance. The review emphasizes the therapeutic potential of plant-derived compounds, which contain immunomodulatory properties that can improve treatment efficacy. By integrating these natural compounds with biotechnology, there is potential for developing new antiviral drugs and therapies. The document focuses on the immunological mechanisms of these bioactive compounds.